Gene · 1909
Papers4,314
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 4,314
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional IgG Autoantibodies against Autonomic Nervous System Receptors in Symptomatic Women with Silicone Breast Implants. | Cells | 2023 | 37296631 | PubTator, text mining | PubMed |
| V2 vasopressin receptor mutations: future personalized therapy based on individual molecular biology. | Front Endocrinol (Lausanne) | 2023 | 37293495 | PubTator, text mining | PubMed |
| Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials. | Nat Med | 2023 | 37291212 | PubTator, text mining | PubMed |
| NoVaTeST: identifying genes with location-dependent noise variance in spatial transcriptomics data. | Bioinformatics | 2023 | 37285319 | PubTator, text mining | PubMed |
| What else can we do to prevent diabetic retinopathy? | Diabetologia | 2023 | 37277664 | PubTator, text mining | PubMed |
| Early diabetic kidney disease: Focus on the glycocalyx. | World J Diabetes | 2023 | 37273258 | PubTator, text mining | PubMed |
| Alterations in pulmonary vasomotor modulators post aerobic exercise training in non-alcoholic fatty liver disease. | Respir Physiol Neurobiol | 2023 | 37269888 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals the potential biological mechanism of AIS and lung adenocarcinoma. | Front Neurol | 2023 | 37265472 | PubTator, text mining | PubMed |
| Copeptin as a Biomarker of Microcirculation Alterations in Systemic Sclerosis. | Clin Cosmet Investig Dermatol | 2023 | 37255624 | PubTator, text mining | PubMed |
| Association between Body Composition and the Risk of Portopulmonary Hypertension Assessed by Computed Tomography in Patients with Liver Cirrhosis. | J Clin Med | 2023 | 37240457 | PubTator, text mining | PubMed |
| Calcium Homeostasis, Transporters, and Blockers in Health and Diseases of the Cardiovascular System. | Int J Mol Sci | 2023 | 37240147 | PubTator, text mining | PubMed |
| Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion. | Biomedicines | 2023 | 37239123 | PubTator, text mining | PubMed |
| Tissue Factor Pathway Inhibitors as Potential Targets for Understanding the Pathophysiology of Preeclampsia. | Biomedicines | 2023 | 37238908 | PubTator, text mining | PubMed |
| Sphingolipid Levels and Signaling via Resveratrol and Antioxidant Actions in Cardiometabolic Risk and Disease. | Antioxidants (Basel) | 2023 | 37237968 | PubTator, text mining | PubMed |
| 20-Hydroxyeicosatetraenoic acid (20-HETE): Bioactions, receptors, vascular function, cardiometabolic disease and beyond. | Adv Pharmacol | 2023 | 37236760 | PubTator, text mining | PubMed |
| The impact of collateral status on cerebral vasospasm and delayed cerebral ischemia in subarachnoid hemorrhage. | J Cerebrovasc Endovasc Neurosurg | 2023 | 37232069 | PubTator, text mining | PubMed |
| Mycobacterium tuberculosis genotypes in an ethnically diverse area with millions of pilgrims and thousands of immigrants. | BMC Infect Dis | 2023 | 37231348 | PubTator, text mining | PubMed |
| Investigation of artificial intelligence integrated fluorescence endoscopy image analysis with indocyanine green for interpretation of precancerous lesions in colon cancer. | PLoS One | 2023 | 37228164 | PubTator, text mining | PubMed |
| Population pharmacokinetic analysis of sparsentan in healthy volunteers and patients with focal segmental glomerulosclerosis. | CPT Pharmacometrics Syst Pharmacol | 2023 | 37221817 | PubTator, text mining | PubMed |
| Molecular mechanism of fatty acid activation of FFAR1. | Proc Natl Acad Sci U S A | 2023 | 37216523 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1909/papers?page=19